Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Assets: 2019-2021

  • Bright Minds Biosciences' Assets was N/A to $22.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $22.2 million, marking a year-over-year change of. This contributed to the annual value of $654,859 for FY2020, which is 954.21% up from last year.
  • According to the latest figures from Q2 2021, Bright Minds Biosciences' Assets is $22.2 million, which was up 3,263.19% from $660,535 recorded in Q3 2020.
  • Bright Minds Biosciences' Assets' 5-year high stood at $22.2 million during Q2 2021, with a 5-year trough of $62,119 in Q3 2019.
  • Moreover, its 3-year median value for Assets was $660,535 (2020), whereas its average is $7.6 million.
  • Data for Bright Minds Biosciences' Assets shows a peak YoY surged of 963.34% (in 2020) over the last 5 years.
  • Bright Minds Biosciences' Assets (Quarterly) stood at $62,119 in 2019, then surged by 963.34% to $660,535 in 2020, then reached $22.2 million in 2021.
  • Its Assets stands at $22.2 million for Q2 2021, versus $660,535 for Q3 2020 and $62,119 for Q3 2019.